2.2 Continous dopaminergic stimulation: concept and evidence
Review
In: Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.
Authors
Leo Verhagen Metman
1
,
M. Maral Mouradian
2
Book Editors
Per Odin
1
2
,
K Ray Chaudhuri
3
2
,
Sten-Magnus Aquilonious
2
,
Ulrika Mundt-Petersen
2
Affiliations
1
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
2
RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Book Affiliations
1
Lund, Sweden
2
Uppsala, Sweden
3
London, UK
PMID:
39208181
Bookshelf ID:
NBK604718
No abstract available
© 2023 Empowering Strategic Performance Ltd.
Sections
The role of dopaminergic neuronal degeneration in the development of motor complications
Pre-clinical evidence in support of loss of dopamine storage in the genesis of motor complications with advancing PD
The role of intermittent L-dopa administration in the development of motor complications
Central pharmacodynamic changes induced by long-term intermittent L-dopa therapy can be partly reversible
Support for continuous dopaminergic stimulation
References
Publication types
Review